Panel Lifts Stay, Reaffirms That Drug Patents Are Invalid
WASHINGTON, D.C. — A per curiam panel of the Federal Circuit U.S. Court of Appeals on Aug. 7 reversed a New Jersey federal judge’s determination that two patents relating to the...To view the full article, register now.
Already a subscriber? Click here to view full article